RxDoctor Payments Data

Steven King, MD

Psychiatry · Youngstown, OHNPI 1609971084

Payments from drug & device makers

$1,533in general payments, 2019–2025

Across 97 payments — averaging $15.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$304
  • Vanda Pharmaceuticals Inc.$245
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$209
  • Lundbeck LLC$166
  • Takeda Pharmaceuticals U.S.A., Inc.$152
  • Otsuka America Pharmaceutical, Inc.$121
  • plus $337 from 12 others

What the payments were for

  • Food & beverage$1,42493%
  • Education$1047%
  • Gifts$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,533 in reported general payments places this provider in the 75th percentile of 1,119 psychiatry providers in Ohio.

See all psychiatry providers in Ohio

Medicare billing

Part B allowed, 2024
$143,227
Medicare patients
162
Services billed
1,184

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole133$208,192
AustedoDeutetrabenazine32$207,886
FanaptIloperidone60$117,872
Aripiprazole396$88,993
VraylarCariprazine Hcl46$75,792
Chlorpromazine Hcl122$50,403
TrintellixVortioxetine Hydrobromide69$40,154
BelsomraSuvorexant67$30,607
Invega SustennaPaliperidone Palmitate14$28,546
Clozapine289$20,976
Divalproex Sodium537$17,660
Clomipramine Hcl27$15,085
Lurasidone Hcl62$15,039
Olanzapine610$14,882
XanaxAlprazolam24$11,686

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$121$208,192133 claims
Vanda Pharmaceuticals Inc.Fanapt$245$117,87260 claims
AbbVieVraylar, Fetzima$304$82,85660 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$152$44,80380 claims
MerckBelsomra$13$30,60767 claims
Johnson & JohnsonInvega Sustenna$41$28,54614 claims
Avanir Pharmaceuticals, Inc.Nuedexta$11$9,87211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,119 psychiatry providers in Ohio.

Other psychiatry in Youngstown

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →